MindBio Therapeutics Expands Shareholder Base
Company Announcements

MindBio Therapeutics Expands Shareholder Base

Mindbio Therapeutics Corp. (TSE:MBIO) has released an update.

MindBio Therapeutics Corp. has announced a significant financial move as Riverfort Global Opportunities PCC Ltd has agreed to convert a CAD$100,000 loan into 2,000,000 shares of MindBio at $0.05 each, with a four-month hold period. The company is at the forefront of mental health treatment innovation, conducting pioneering take-home microdosing clinical trials with its leading drug candidate, MB22001, a unique form of LSD tailored for microdosing purposes.

For further insights into TSE:MBIO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskMindBio Advances in Psychedelic Medicine Trials
TipRanks Canadian Auto-Generated NewsdeskMindBio’s LSD Microdosing Shows Lasting Depression Relief
TipRanks Canadian Auto-Generated NewsdeskMindBio Partners with Haywood for Investment Strategy
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App